BRAFV600E immunoprofiling in precancerous and cancerous lesions of the breast by immunohistochemistry and to study its association with clinicopathological features.
Not Applicable
- Conditions
- Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
- Registration Number
- CTRI/2023/06/053430
- Lead Sponsor
- Indian council of medical research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
The cases diagnosed on biopsy or surgical specimen of breast cancer.
Exclusion Criteria
1. Breast Biopsy with inflammatory histomorphology.
2. The biopsy without representative histomorphology of precancerous and cancerous lesion.
3. Deficient clinical data and details.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary Outcome:To study the expression of BRAFV600E in relation to prognosis and predictions to outcome. <br/ ><br>Timepoint: 2 years
- Secondary Outcome Measures
Name Time Method Seconday outcome:This study will determine the significance of immunoprofiling of BRAFV600E in breast cancer. <br/ ><br>Timepoint: 2 years